Veru (STU:FMW) Other Long-Term Liabilities : €4.40 Mil (As of Jun. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Veru Other Long-Term Liabilities?

Veru's other long-term liabilities for the quarter that ended in Jun. 2024 was €4.40 Mil.

Veru's quarterly other long-term liabilities increased from Dec. 2023 (€0.00 Mil) to Mar. 2024 (€4.59 Mil) but then declined from Mar. 2024 (€4.59 Mil) to Jun. 2024 (€4.40 Mil).

Veru's annual other long-term liabilities increased from Sep. 2021 (€0.01 Mil) to Sep. 2022 (€0.02 Mil) and increased from Sep. 2022 (€0.02 Mil) to Sep. 2023 (€0.03 Mil).

Veru Other Long-Term Liabilities Historical Data

The historical data trend for Veru's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Other Long-Term Liabilities Chart

Veru Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Veru Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Veru Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Veru Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Veru's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Veru Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

VERU:USA FMW:Germany

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru Headlines

No Headlines